Project Grant HT9425261E171
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Palo Alto Veterans Institute for Research (PAVIR) $923,000 through the Military Medical Research and Development program (CFDA 12.420) to conduct research on engagement of veterans with lung cancer. The three-year project, spanning August 1, 2025 through July 31, 2028, is being performed at PAVIR's facility in Palo Alto, California. This research initiative aligns with the DHA's broader mission to transform healthcare...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1,076,615 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026 through June 30, 2029. This research initiative, titled "Study of Endothelial-to-Mesenchymal Transition and Cardiovascular Disease in Veterans with Burn Pit Exposures Using Advanced Imaging and 3D Heart Tissue Models," will be conducted at Stanford's...
- This $1,400,500.00 Project Grant was awarded on August 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute For Research (PAVIR), a nonprofit foundation. The funding will support PAVIR's research efforts over a 3-year period ending on August 14, 2026 to investigate the role of inflammatory astrocyte reactivity in mild traumatic brain injury. PAVIR has extensive experience conducting medical research...
- Federal Grant Award Summary The Defense Health Agency awarded $715,213 under the Military Medical Research and Development program (CFDA 12.420) to Veterans Education and Research Association of Northern New England, Inc. (VERANNE) on September 30, 2025, with completion anticipated by September 29, 2029. The project, titled "Use of Bile Acid-Binding Resins to Decrease Systemic Per- and Polyfluoroalkyl Substance (PFAS) Levels and Improve Serum Lipid Profiles in Veterans," will be...
- This Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $1,010,604 in federal funding to Livermore Lab Foundation to investigate the adverse neurological effects resulting from inhalation exposure to burn pits. The award was transferred to the awardee with modification and is effective from August 1, 2025, through July 31, 2028. Research will be conducted at the awardee's facility in Livermore,...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Metis Foundation a $864,533 Project Grant effective September 30, 2025, through September 29, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports research investigating the relationship between per- and polyfluoroalkyl substances (PFAS) and other toxic military exposures with pancreatic cancer risk in military populations. Research will be conducted at the awardee's...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Stanford University a $832,270 Project Grant effective July 1, 2025, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports high-throughput in vivo lung cancer pharmacogenomics research conducted at Stanford's Palo Alto, California facility. This research initiative will deliver advanced biomedical research services focused on investigating innovative medical...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.19 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. This four-year research initiative addresses toxicant-mediated pulmonary hypertension in Southwest Asia veterans, supporting advanced biomedical research designed to transform healthcare for military service members and...
- Federal Grant Award Summary The Veterans Medical Research Foundation of San Diego received a $4.8 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. This award funds a hybrid Type I evaluation of integrative health care interventions for Post-Traumatic Stress Disorder (PTSD), combining rigorous clinical trial methodology with implementation...
- This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $284,000.00 to the Palo Alto Veterans Institute For Research (PAVIR) to conduct research on novel Fc receptor blockers as potential disease-modifying analgesics. The research will take place from July 1, 2024 to June 30, 2026. PAVIR is a non-profit organization closely affiliated with the VA and Stanford University that has a long history of securing federal grants and...
The Defense Health Agency (DHA) awarded Palo Alto Veterans Institute For Research (Pavir) a $1.163 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The award funds research investigating endothelial-to-mesenchymal transition and cardiovascular disease in veterans exposed to burn pit emissions through advanced imaging techniques and three-dimensional heart tissue models. This research initiative addresses military health priorities by developing innovative diagnostic and therapeutic approaches to understand burn pit-related cardiovascular complications affecting service members and veterans. Pavir will deliver hypothesis-driven research and development services, including biomarker discovery, advanced imaging analysis, and translational research utilizing three-dimensional tissue models to characterize cardiovascular disease mechanisms in the exposed veteran population. As a research hub affiliated with VA Palo Alto Health Care System and Stanford University, Pavir will leverage established collaborative networks and research infrastructure to conduct this investigation at its Palo Alto, California location. The three-year award reflects DHA's investment in basic and applied biomedical research designed to transform healthcare for military service members and the American public through innovative medical solutions addressing critical health challenges related to environmental exposures.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 5/11/26 |